Can Propranolol Be Used in Pregnancy?
Yes, propranolol can be used during pregnancy when clinically indicated, but it should be avoided during the first trimester if possible, and patients require monitoring for potential fetal effects including intrauterine growth retardation. 1, 2, 1
Clinical Recommendation Framework
When Propranolol Is Appropriate
Propranolol is considered a safe first-line agent for ongoing management of cardiac conditions during pregnancy, particularly for:
- Supraventricular tachycardia (SVT) requiring chronic prophylaxis 1
- Hypertrophic cardiomyopathy (HCM) 2
- Acute conversion of paroxysmal SVT (Class IIa recommendation) 3
The 2016 ACC/AHA/HRS guidelines specifically list propranolol among drugs that "can be effective for ongoing management in pregnant patients with highly symptomatic SVT" with a Class IIa recommendation 1. The 2024 HCM guidelines note that "most beta blockers (ie, metoprolol, bisoprolol, labetalol, pindolol, propranolol) are generally considered safe to use during pregnancy" 2.
Critical Timing Considerations
First Trimester Avoidance: All major guidelines emphasize avoiding propranolol during the first trimester when possible, as this is the period of greatest teratogenic risk and concern for congenital malformations 1, 3, 1, 3. The 2003 ACC/AHA/ESC guidelines explicitly state "beta-blocking agents should not be taken in the first trimester, if possible" 3.
Second and Third Trimester Use: After the first trimester, propranolol is considered relatively safe with appropriate monitoring 1.
Important Safety Concerns and Monitoring
Intrauterine Growth Retardation (IUGR)
The most significant concern with propranolol is intrauterine growth retardation, which has been consistently reported across guidelines 1, 3, 1, 3. This effect appears less pronounced than with atenolol, which is contraindicated (FDA Category D) due to more severe growth retardation and higher rates of preterm delivery 1, 3.
The FDA drug label confirms: "Intrauterine growth retardation, small placentas, and congenital abnormalities have been reported in neonates whose mothers received propranolol during pregnancy" 4.
Neonatal Effects at Delivery
Neonates whose mothers receive propranolol at parturition may exhibit 4:
- Bradycardia
- Hypoglycemia
- Respiratory depression
Adequate facilities for monitoring such infants at birth should be available 4. The 2024 HCM guidelines recommend "closer monitoring of fetal growth and surveillance for fetal bradycardia may be considered for pregnant women on beta blockers" 2.
Dosing Strategy
- Use the lowest effective dose initially, with adjustments based on clinical response 1
- Propranolol has a longer safety record compared to newer agents 1
- The 2015 ESC guidelines classify propranolol as FDA Category C, meaning potential benefits may outweigh risks 5
Comparison to Other Beta-Blockers
Propranolol vs. Atenolol: Atenolol is specifically contraindicated (Class III recommendation) due to significantly higher risk of growth retardation, especially with earlier gestational age exposure and longer treatment duration 1, 3. Propranolol is preferred over atenolol.
Propranolol vs. Metoprolol: Both are considered safe first-line agents with similar safety profiles 1. Metoprolol receives a slightly higher recommendation (Class I vs. Class IIa for prophylactic therapy) in some guidelines 3, though both are acceptable choices.
Common Pitfalls to Avoid
Don't use atenolol: This is the only beta-blocker with a Class III (harm) recommendation and FDA Category D classification 3
Don't assume all reported adverse effects are drug-related: The 2003 guidelines note that "rare cases of adverse effects on the fetus, including bradycardia, hypoglycemia, premature labor, and metabolic abnormalities, have been reported but may be secondary to fetal distress in high-risk pregnancies" 3
Don't forget neonatal monitoring: Ensure pediatric facilities are prepared for potential neonatal bradycardia, hypoglycemia, and respiratory depression at delivery 4
Don't continue unnecessarily: If symptoms are mild and the patient has a structurally normal heart, reassurance alone may be sufficient 3
FDA Classification and Drug Label Information
Propranolol is FDA Pregnancy Category C 4, meaning:
- Animal studies showed embryotoxicity at high doses (150 mg/kg/day in rats) but not at lower doses
- No adequate and well-controlled studies exist in pregnant women
- Should be used "only if the potential benefit justifies the potential risk to the fetus" 4
The drug label emphasizes that while animal studies at doses equivalent to maximum recommended human doses showed no embryo or neonatal toxicity in rabbits, clinical reports in humans have documented growth retardation and other complications 4.
Breastfeeding Considerations
Propranolol is excreted in breast milk, but milk:plasma ratios are less than 1, with estimated daily infant intake of only about 3 micrograms 6. The drug label states "caution should be exercised" but does not contraindicate breastfeeding 4.